• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY Back to Search Results
Lot Number VMFA131023
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Pleural Effusion (2010); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 02/27/2024
Event Type  Injury  
Event Description
It has been reported that a versacross connect access solution was selected for use.A perforation, pericardial effusion and pleural effusion were noted, causing the procedure to be cancelled.During a watchman left atrial appendage closure (laac) procedure, the physician mentioned that transseptal puncture was performed successfully using the versacross connect, and the versacross rf wire was visualized in the left atrium (la).Thus, the versacross dilator was removed, and a non-boston scientific pigtail catheter was inserted and advanced it into the appendage distally.They then used dye to visualize the appendage and observed that the dye had gone into the pericardium.The patient's blood pressure began to drop, heparin was reversed, and a pericardial drain was inserted.The patient has been admitted to the hospital beyond the standard of care and is expected to fully recover.Product is not expected to return as it was disposed of at the facility.The patient received a clip the next day and was discharged the following day.No issues were noted with versacross devices.They were unable to get an act measurement, but heparin was confirmed to be reversed.In the physician's opinion, the versacross devices did not malfunction during the procedure.It is believed that it was the non-boston scientific pigtail catheter that was advanced into the laa that went through the wall of the appendage.In the physician's opinion, the appendage was perforated while performing an appendage gram.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
CATHETER, SEPTOSTOMY
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18951065
MDR Text Key338257906
Report Number2124215-2024-16636
Device Sequence Number1
Product Code DXF
UDI-Device Identifier00685447012597
UDI-Public00685447012597
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K150709
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberVMFA131023
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/27/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/16/2023
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age75 YR
Patient SexFemale
Patient RaceWhite
-
-